CCLG’s partnership with the Little Princess Trust honoured at Third Sector Awards

  • Published:

Children’s Cancer and Leukaemia Group (CCLG)’s successful research-funding partnership with the Little Princess Trust (LPT) has been recognised at a prestigious awards ceremony.

The partnership, which sees the LPT use CCLG’s established infrastructure and expertise to ensure it’s able to fund the best possible research, was highly commended in the Charity Partnership of the Year category at last week’s (22 September) Third Sector Awards.

It began in 2016, when the LPT’s trustees wanted to expand its remit to fund childhood cancer research, but with no previous experience or contacts within the research community, they needed support in getting started.

This led to conversations between LPT and CCLG to explore how the two organisations could work together to fund world-class research into finding kinder, more effective treatments for childhood cancers.

By sharing knowledge and resources, the partnership has provided a huge boost to childhood cancer research in the UK and, as a result of the collaboration, more than £20million in funding has been awarded to pioneering institutions and experts leading the way in researching paediatric cancers.

The partnership has also acted as a road map for other charities to follow by showing just how much can be achieved when different organisations come together to help others.

Ashley Ball-Gamble, CCLG CEO, said:

We’re delighted that our partnership with The Little Princess Trust has been recognised for its impact in enabling ground-breaking research to be funded more quickly, and without the duplication of time and resources. Our position as the experts in childhood cancer makes us ideally placed to support and administer the LPT’s extensive research funding portfolio.

The partnership is key to both our long-term aims and allows more high-quality research to be funded. By working together, we are stronger, and through collaborations such as this, we can achieve our goals quicker, and ultimately help shape a brighter future for children with cancer.